NLS Pharmaceutics Ltd (NLSP)
0.1533
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics SG&A Expense (Quarterly)
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
AC Immune SA | 5.688M |
CRISPR Therapeutics AG | 17.95M |
Addex Therapeutics Ltd | 1.922M |
Molecular Partners AG | 5.036M |
MoonLake Immunotherapeutics | 6.806M |